Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 14:11:1490340.
doi: 10.3389/fnut.2024.1490340. eCollection 2024.

Mediation of endothelial activation and stress index in the association between vitamin B6 turnover rate and diabetic retinopathy: an analysis of the National Health and Nutrition Examination Survey

Affiliations

Mediation of endothelial activation and stress index in the association between vitamin B6 turnover rate and diabetic retinopathy: an analysis of the National Health and Nutrition Examination Survey

Jie Yin et al. Front Nutr. .

Abstract

Aim: This study aimed to explore the association between the ratio of 4-pyridoxine (4-PA) to pyridoxal 5'-phosphate (PLP) (4-PA/PLP) and diabetic retinopathy (DR) and further assess the mediating effect of Endothelial Activation and Stress Index (EASIX) on the association between 4-PA/PLP and DR.

Methods: In this cross-sectional study, 1,698 patients with diabetes from the National Health and Nutrition Examination Survey were included. According to the median, 4-PA/PLP was categorized into a high-level group (≥0.89) and a low-level group (<0.89). As the EASIX had a skewed distribution, it was log-transformed before analysis. Weighted logistic regression models were used to investigate the association of 4-PA/PLP with EASIX and DR and the mediating effect of EASIX on the association between 4-PA/PLP and DR. The distribution-of-product method was adopted to assess the mediating effect. Subgroup analysis was performed based on the age and duration of diabetes.

Results: A total of 362 diabetic patients were classified as having DR. After adjusting for all covariates, a higher level of 4-PA/PLP was associated with an increased level of log EASIX [odds ratio (OR) = 1.56, 95% confidence interval (CI): 1.06-2.30]. A higher ratio of 4-PA/PLP was associated with increased odds of DR compared to the reference group with lower levels of 4-PA/PLP (OR = 1.94, 95%CI: 1.40-2.67). In addition, we found that log EASIX may play a mediating role in the 4-PA/PLP and DR, with a 95% CI of distribution of product of 0.31 (95% CI: 0.02-0.67). The proportion of mediation was 69.06%. The mediating effect of log EASIX was also observed in individuals with diabetes who were aged≥60 years (proportion of mediation: 50.63%) or had a duration of diabetes ≥10 years (proportion of mediation: 71.83%).

Conclusion: This study found a positive association between high levels of 4-PA/PLP and an increased risk of DR, with the relationship being partially mediated by log EASIX.

Keywords: 4-PA/PLP; DR; EASIX; distribution-of-product method; mediating effect.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the participants screening. NHANES, National Health and Nutrition Examination Survey; 4-PA, 4-pyridoxine; PLP, pyridoxal 5′-phosphate; LDH, lactate dehydrogenase; DR, diabetic retinopathy.
Figure 2
Figure 2
Path diagram of the mediation analysis models. Path a: estimated coefficient for the regression with 4-PA/PLP predicting log EASIX; Path b: estimated coefficient for the regression with log EASIX predicting DR; Path c = total effects for the regression with 4-PA/PLP predicting DR; Path c’ = direct effects for the regression with 4-PA/PLP predicting DR independent of log EASIX. 4-PA/PLP: the ratio of 4-pyridoxine (4-PA) to pyridoxal 5′-phosphate (PLP); EASIX: Endothelial Activation and Stress Index; DR: diabetic retinopathy.

Similar articles

Cited by

References

    1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. (2010) 376:124–36. doi: 10.1016/s0140-6736(09)62124-3, PMID: - DOI - PubMed
    1. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. . Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and Meta-analysis. Ophthalmology. (2021) 128:1580–91. doi: 10.1016/j.ophtha.2021.04.027, PMID: - DOI - PubMed
    1. Modjtahedi BS, Wu J, Luong TQ, Gandhi NK, Fong DS, Chen W. Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality. Ophthalmology. (2021) 128:1169–79. doi: 10.1016/j.ophtha.2020.12.019, PMID: - DOI - PubMed
    1. Gui F, You Z, Fu S, Wu H, Zhang Y. Endothelial dysfunction in diabetic retinopathy. Front Endocrinol. (2020) 11:591. doi: 10.3389/fendo.2020.00591, PMID: - DOI - PMC - PubMed
    1. Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol. (2022) 13:816400. doi: 10.3389/fendo.2022.816400, PMID: - DOI - PMC - PubMed

LinkOut - more resources